Radioactive compound for treatment of melanoma and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12194109
APP PUB NO 20210113719A1
SERIAL NO

17134709

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a radioactive compound with improved targeting ability for melanoma and a pharmaceutical composition for the treating melanoma comprising the same, and the targeting ability for melanoma is improved as compared to the conventional contrast agent for melanoma. The radioactive compound according to an embodiment of the present invention shows a very excellent therapeutic effect on melanoma.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY300 YONGBONG-DONG BUK-GU GWANGJU 500-757

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kim, Dong-Yeon Jeollanam-do, KR 54 139
Min, Jung-Joon Gwangju, KR 11 10
Pyo, A-Young Gwangju, KR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 14, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 14, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 14, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00